O
OrbiMed’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,214,937
| Closed | -$23.7M | – | 128 |
|
|
2023
Q2 | $23.7M | Sell |
7,214,937
-1,796,500
| -20% | -$5.91M | 0.43% | 64 |
|
|
2023
Q1 | $37M | Hold |
9,011,437
| – | – | 0.73% | 44 |
|
|
2022
Q4 | $52.8M | Hold |
9,011,437
| – | – | 1.01% | 37 |
|
|
2022
Q3 | $60.9K | Hold |
9,011,437
| – | – | 1.13% | 31 |
|
|
2022
Q2 | $41.6K | Buy |
9,011,437
+4,222,537
| +88% | +$19.5K | 0.75% | 44 |
|
|
2022
Q1 | $19.1M | Buy |
4,788,900
+1,900,053
| +66% | +$7.58M | 0.31% | 68 |
|
|
2021
Q4 | $18M | Hold |
2,888,847
| – | – | 0.23% | 88 |
|
|
2021
Q3 | $27.2M | Buy |
2,888,847
+88,600
| +3% | +$836K | 0.3% | 82 |
|
|
2021
Q2 | $38M | Buy |
2,800,247
+907,747
| +48% | +$12.3M | 0.38% | 68 |
|
|
2021
Q1 | $30.6M | Buy |
1,892,500
+1,119,152
| +145% | +$18.1M | 0.29% | 82 |
|
|
2020
Q4 | $20.6M | Sell |
773,348
-555,504
| -42% | -$14.8M | 0.18% | 101 |
|
|
2020
Q3 | $24.7M | Sell |
1,328,852
-581,156
| -30% | -$10.8M | 0.31% | 78 |
|
|
2020
Q2 | $44.7M | Buy |
1,910,008
+563,287
| +42% | +$13.2M | 0.63% | 50 |
|
|
2020
Q1 | $7.85M | Sell |
1,346,721
-726,598
| -35% | -$4.24M | 0.13% | 90 |
|
|
2019
Q4 | $11.9M | Buy |
2,073,319
+182,200
| +10% | +$1.04M | 0.17% | 78 |
|
|
2019
Q3 | $2.99M | Hold |
1,891,119
| – | – | 0.06% | 98 |
|
|
2019
Q2 | $7.66M | Hold |
1,891,119
| – | – | 0.12% | 91 |
|
|
2019
Q1 | $9.95M | Buy |
+1,891,119
| New | +$9.95M | 0.15% | 88 |
|